(Q39774023)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

MVA-5T4-induced immune responses are an early marker of efficacy in renal cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

7

Howard L Kaufman

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Richard Harrop

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

William H Shingler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Mike McDonald

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Robert J Amato

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Robert E Hawkins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Jackie de Belin

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Michelle Kelleher

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Madusha Goonewardena

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Stuart Naylor

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

9 March 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

24 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

829-837

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00262-011-0993-7

24 January 2020

exact match

0 references

cites work

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Renal cell carcinoma: new developments in molecular biology and potential for targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

A 72 kD trophoblast glycoprotein defined by a monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Immunohistological distribution of 5T4 antigen in normal and malignant tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Vaccination of renal cell cancer patients with modified vaccinia ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Vaccination of colorectal cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) induces immune responses which correlate with disease control: a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Vaccination of patients with metastatic renal cancer with modified vaccinia Ankara encoding the tumor antigen 5T4 (TroVax) given alongside interferon-alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

The effect of iron deficiency anemia on the function of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Synergistic inflammation is induced by blood degradation products with microbial Toll-like receptor agonists and is blocked by hemopexin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

Improved Endpoints for Cancer Immunotherapy Trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-0993-7

10.1007/S00262-011-0993-7

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21387109%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference